Page last updated: 2024-08-18

4-butyrolactone and Constriction, Pathologic

4-butyrolactone has been researched along with Constriction, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Filipek, B; Malawska, B; Nowak, B; Sałat, K; Sołtys, Z; Więckowski, K; Witalis, J; Zadrożna, M	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Constriction, Pathologic

Article	Year
3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one and pregabalin attenuate tactile allodynia in the mouse model of chronic constriction injury. Toxicology mechanisms and methods, 2015, Volume: 25, Issue:7 Topics: 4-Butyrolactone; Analgesics; Animals; Constriction, Pathologic; Dose-Response Relationship, Drug; Hot Temperature; Hyperalgesia; Male; Mice; Nerve Growth Factor; Neuralgia; Pain Measurement; Physical Stimulation; Piperazines; Postural Balance; Pregabalin; Sciatic Nerve	2015

Article

Year

3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one and pregabalin attenuate tactile allodynia in the mouse model of chronic constriction injury.

Toxicology mechanisms and methods, 2015, Volume: 25, Issue:7

Topics: 4-Butyrolactone; Analgesics; Animals; Constriction, Pathologic; Dose-Response Relationship, Drug; Hot Temperature; Hyperalgesia; Male; Mice; Nerve Growth Factor; Neuralgia; Pain Measurement; Physical Stimulation; Piperazines; Postural Balance; Pregabalin; Sciatic Nerve

2015